Insights in Behavior of Variably Formulated Alginate-Based Microcapsules for Cell Transplantation

Biomed Res Int. 2015:2015:965804. doi: 10.1155/2015/965804. Epub 2015 May 20.

Abstract

Alginate-based microencapsulation of live cells may offer the opportunity to treat chronic and degenerative disorders. So far, a thorough assessment of physical-chemical behavior of alginate-based microbeads remains cloudy. A disputed issue is which divalent cation to choose for a high performing alginate gelling process. Having selected, in our system, high mannuronic (M) enriched alginates, we studied different gelling cations and their combinations to determine their eventual influence on physical-chemical properties of the final microcapsules preparation, in vitro and in vivo. We have shown that used of ultrapure alginate allows for high biocompatibility of the formed microcapsules, regardless of gelation agents, while use of different gelling cations is associated with corresponding variable effects on the capsules' basic architecture, as originally reported in this work. However, only the final application which the capsules are destined to will ultimately guide the selection of the ideal, specific gelling divalent cations, since in principle there are no capsules that are better than others.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alginates / chemistry*
  • Alginates / therapeutic use
  • Biocompatible Materials / chemistry
  • Biocompatible Materials / therapeutic use*
  • Capsules / chemistry
  • Capsules / therapeutic use
  • Cell Transplantation / methods*
  • Drug Compounding / methods*
  • Gels / chemistry
  • Glucuronic Acid / chemistry
  • Glucuronic Acid / therapeutic use
  • Hexuronic Acids / chemistry
  • Hexuronic Acids / therapeutic use
  • Humans

Substances

  • Alginates
  • Biocompatible Materials
  • Capsules
  • Gels
  • Hexuronic Acids
  • Glucuronic Acid
  • mannuronic acid